TXLNA and pancreatic adenocarcinoma: In conclusion, TXLNA has a high expression in PAAD tissue compared with normal tissue, and its upregulated expression might serve as an independent prognostic indicator of OS, DFI, DSS, and PFI in PAAD patients.